Prosecution Insights
Last updated: October 02, 2026

Examiner: LADD, CAROLYN LOUISE

Tech Center 1600 • Art Units: 1622 1629

This examiner grants 59% of resolved cases

Analysis

Carolyn Louise Ladd is an examiner in Art Unit 1622 of Tech Center 1600. The examiner has 87 resolved cases with an allowance rate of 58.6%. This rate indicates the proportion of applications that have reached allowance under this examiner's review. The median days to allowance for these cases is 1307, providing a timeline for the prosecution process in this art unit. Practitioners can use these figures to evaluate the historical outcomes associated with this examiner.

The data shows an interview lift of 47.1%. This figure indicates that conducting an interview is associated with a 47.1% increase in the probability of allowance compared to the base allowance rate of 58.6%. For practitioners, this suggests that direct communication with the examiner is a method for increasing the likelihood of a grant. The 87 resolved cases provide a statistical basis for evaluating these outcomes. In Tech Center 1600, the 58.6% allowance rate and the 47.1% interview lift are key metrics for planning a prosecution strategy. The 1307 days to allowance serves as the median duration for cases that successfully navigate the examination process to reach an allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

58.6%
Allow Rate
-1.4% vs TC avg
109
Total Applications
+47.1%
Interview Lift
1307
Avg Prosecution Days
Based on 87 resolved cases, 2023–2026

Rejection Statute Breakdown

1.9%
§101 Eligibility
23.0%
§102 Novelty
25.9%
§103 Obviousness
34.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18023318 DOSING SCHEDULE FOR A METHOD OF TREATMENT WITH DHODH INHIBITORS Final Rejection Bayer Aktiengesellschaft
17266488 COMPOSITIONS AND METHODS FOR TREATING CANCER AND AUTOIMMUNE DISEASES Final Rejection CEDARS-SINAI MEDICAL CENTER
18833468 COMPOUNDS AND METHODS OF USE Non-Final OA Tango Therapeutics, Inc.
18833315 COMPOUNDS AND METHODS OF USE Non-Final OA Tango Therapeutics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month